---
title: "Overview of A-share lock-up stock release: Lock-up stocks with a market value of 25.318 billion yuan are released today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245594061.md"
description: "On Monday, a total of 16 companies had their restricted shares unlocked, with a total unlock volume of 4.291 billion shares and an unlock market value of 25.318 billion yuan. CRCHI, BIOCAUSE HEILEN PHARMA, and Huaru Technology had the highest unlock volumes, at 3.856 billion shares, 216 million shares, and 7.1625 million shares, respectively. In terms of unlock market value, CRCHI, BIOCAUSE HEILEN PHARMA, and CARVE had unlock market values of 15.229 billion yuan, 3.627 billion yuan, and 1.969 billion yuan, respectively. Five companies had an unlock ratio exceeding 10%, with BIOCAUSE HEILEN PHARMA, CRCHI, and CARVE having unlock ratios of 75.0%, 72.29%, and 60.08%, respectively"
datetime: "2025-06-22T23:35:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245594061.md)
  - [en](https://longbridge.com/en/news/245594061.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245594061.md)
---

# Overview of A-share lock-up stock release: Lock-up stocks with a market value of 25.318 billion yuan are released today

According to Wind data, on Monday, a total of 16 companies had their restricted shares unlocked, with a total unlocking volume of 4.291 billion shares. Based on the latest closing price, the total market value of the unlocked shares is 25.318 billion yuan. In terms of unlocking volume, 6 companies had more than 10 million shares unlocked. CRCHI, BIOCAUSE HEILEN PHARMA, and Huaru Technology had the highest unlocking volumes, with 3.856 billion shares, 216 million shares, and 7.1625 million shares, respectively. In terms of unlocking market value, 6 companies had unlocking volumes exceeding 100 million yuan. CRCHI, BIOCAUSE HEILEN PHARMA, and CARVE had the highest unlocking market values, with 15.229 billion yuan, 3.627 billion yuan, and 1.969 billion yuan, respectively. In terms of the proportion of unlocked shares to total share capital, 5 companies had an unlocking ratio exceeding 10%. BIOCAUSE HEILEN PHARMA, CRCHI, and CARVE had the highest unlocking ratios, at 75.0%, 72.29%, and 60.08%, respectively

### Related Stocks

- [301182.CN](https://longbridge.com/en/quote/301182.CN.md)
- [688425.CN](https://longbridge.com/en/quote/688425.CN.md)
- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)
- [301302.CN](https://longbridge.com/en/quote/301302.CN.md)

## Related News & Research

- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [Weichai Digital Industrial Park wins internal combustion engine industry’s first zero-carbon factory certification](https://longbridge.com/en/news/296162029.md)
- [REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/296096467.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)
- [MTN Rwanda releases H1 2026 results on Rwanda Stock Exchange](https://longbridge.com/en/news/296245062.md)